The p53-related transcription factor p63 is required for maintenance of epithelial cell differentiation. We found that activated forms of the Harvey Rat Sarcoma Virus GTPase (H-RAS) and phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) oncogenes strongly repress expression of ΔNp63α, the predominant p63 isoform in basal mammary epithelial cells. This regulation occurs at the transcriptional level, and a short region of the ΔNp63 promoter is sufficient for repression induced by H-RasV12. The suppression of ΔNp63α expression by these oncogenes concomitantly leads to an epithelial-tomesenchymal transition (EMT). In addition, the depletion of ΔNp63α alone is sufficient to induce EMT. Both H-RasV12 expression and ΔNp63α depletion induce individual cell invasion in a 3D collagen gel in vitro system, thereby demonstrating how Ras can drive the mammary epithelial cell state toward greater invasive ability. Together, these results suggest a pathway by which RAS and PIK3CA oncogenes induce EMT through regulation of ΔNp63α.
H -Ras, a member of the Ras family of GTPases, was originally identified as the transforming protein encoded by the Harvey rat sarcoma retrovirus (1) . Activating mutations in H-Ras and its family members, K-Ras and N-Ras, were identified in a variety of cancers, and nearly 30% of all cancers have mutations in one of the Ras genes (2, 3) . The EGFR2 receptor, also known as HER2/ neu, is an important upstream activator of Ras and is amplified in about 20-30% of breast cancers (4, 5) . Although many HER2 + cancers are initially responsive to treatment with the monoclonal antibody Herceptin (trastuzumab), resistance usually develops (6, 7) . Therefore, it is of great importance to understand signaling pathways that are downstream of HER2 and Ras, to identify key factors responsible for their tumor-promoting effects. It may also be possible to target such factors, in combination with HER2 or Ras inhibitors, to achieve greater clinical efficacy.
A major effector downstream of Ras is the phosphatidylinositol 3-kinase (PI3K) pathway. The catalytic subunit of PI3K, PIK3CA, is frequently found mutated in cancers, especially those cancers originating in the breast (8, 9) . Like mutant Ras, expression of mutant PIK3CA can cause nontumorigenic cells to undergo transformation and gain invasive abilities (10, 11) . Carcinoma cells, in particular, may gain increased invasive abilities by undergoing an epithelial-to-mesenchymal transition (EMT), where adherens junctions formed by E-cadherin are disrupted (12, 13) . Canonical transcription factors that repress E-cadherin include Twist, Snail, Slug, and Zeb1, although this network has grown more complex in recent years (14, 15) .
The transcription factor p63 not only induces transcription of canonical p53 targets but is also a master regulator of epithelial cells (16, 17) . Mice losing both alleles of p63 display complications due to the loss of epithelial stratification, including the absence of mammary glands (18, 19) . They also have significant craniofacial and limb abnormalities, indicating that p63 plays a key role in embryonic development. There are many isoforms of p63, including the major types TAp63 and ΔNp63, which are transcribed from alternative start sites (20) . There is also alternative splicing at the 3′ end, resulting in the isoforms α, β, and γ (20) . ΔNp63 was determined to be responsible for the aforementioned characteristics in mice, because isoform-specific knockdown led to similar epidermal defects (21, 22) .
Interestingly, the role of p63 in cancer is controversial, possibly due to the different activities of its various isoforms and/or tissue specificity. In head and neck squamous cell carcinomas, the p63 locus is often amplified, suggesting an oncogenic role (23) . However, in other types of tumors, basal epithelial markers like p63 and keratin 14 are lost (24) (25) (26) , and ΔNp63 has been found to suppress EMT in prostate and bladder cancer cells (27, 28) . Surprisingly, in one report, ΔNp63α and ΔNp63β were found to inhibit, whereas ΔNp63γ promoted, EMT in MCF10A mammary epithelial cells (29) . These conflicting results make it important to determine the effects of p63 on cell growth, differentiation, and invasiveness in different cell types.
We endeavored to study gene and network changes downstream of Ras in mammary epithelial cells. Our analysis of these changes indicates that H-RAS and PIK3CA oncogenes can induce EMT via repression of p63.
Significance
The oncogenes Harvey Rat Sarcoma Virus GTPase (H-RAS) and phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) are well known for altering cell growth and morphology. We show here that they are also able to modify the differentiation state of mammary epithelial cells by inducing an epithelial-to-mesenchymal transition (EMT). This transition leads to greater invasiveness, a hallmark of the progression of tumors toward metastasis. Expression of p63, a protein required for the development of mammary epithelial cells, is strongly repressed by these oncogenes. In turn, loss of p63, which occurs at the transcriptional level, causes a shift in microRNAs and transcription factors that control EMT. Targeting specific genes within this Ras-to-EMT axis may be useful as a therapy to block breast cancer progression.
Results
We were originally interested in how the H-Ras and p53 pathways might interact to regulate gene expression. For this purpose, we used a pair of isogenic MCF10A cell lines, one with wild-type (WT) p53 and another with a homozygous deletion of p53's second exon leading to the loss of functional p53 protein (termed "p53-del" here; clone 1A from ref. 30 ). MCF10A is a nontransformed mammary epithelial cell line that was spontaneously immortalized after derivation ex vivo from a healthy woman who underwent reduction mammoplasty (31) . This line is thought to derive from myoepithelial cells because they express p63, keratin 5, and keratin 14 (32) . Activated H-RasV12 or the empty vector (hereafter, Vector) were introduced into both p53 WT and p53-del MCF10A cell lines by retroviral transduction. Expression of H-Ras was confirmed by immunoblots and quantitative RT-PCR (qPCR) (Fig.  1A and Fig. S1A ). The morphology of the H-Ras cells was altered, as previously seen for the comparable cell line MCF10AT (33) (Fig. S1B) . Although the Vector lines remained cobblestone-like when confluent, characteristic of epithelial cells, the two lines expressing mutant H-Ras displayed an elongated shape with loss of cell-to-cell attachments (Fig. S1B) . We also found that the H-Rasinfected cell lines, but not the Vector-infected cell lines, formed large colonies in soft agar, demonstrating anchorage-independent growth (Fig. S1B ), indicating their transformed properties.
To assess gene expression changes and identify novel targets downstream of H-Ras and p53, we performed RNA-sequencing (RNA-Seq) for the four cell lines. A Venn diagram of genes significantly regulated by H-RasV12 (fold change > 2 and P < 0.05) is shown for the p53-del and WT cell lines (Fig. 1B) . Interestingly, the total number of significantly changed targets was smaller in the WT-p53 set of cell lines than in the p53-del set of cell lines, suggesting that the presence of p53 has a dampening effect on H-Ras-activated signaling pathways.
There was an overlap of 821 genes up-or down-regulated by H-Ras in both the p53-del and WT cell lines, which are listed in Dataset S1A. Genes uniquely regulated by H-Ras in the p53-del and WT cell lines are listed in Dataset S1 B and C. In addition to H-Ras, which was elevated due to its introduction into these cell lines, a number of mesenchymal genes, including Zeb1, Zeb2, Vimentin (VIM), N-cadherin (CDH2), and Fibronectin (FN1), were within the top 100 significantly up-regulated targets ( Fig.  S1C and Dataset S1A). This finding suggested that the cells had undergone EMT. Correspondingly, genes associated with the epithelial state were significantly down-regulated, including E-cadherin (CDH1), miR-205 host gene (MIR205HG), keratin 5 (KRT5), grainyhead-like transcription factor 2 (GRHL2), and epithelial splicing regulatory protein 1 (ESRP1) (Fig. 1C and Dataset S1A). Interestingly, TP63, a transcription factor associated with the epithelial state, was the second and sixth most significantly downregulated target in WT-p53 and p53-del cells, respectively. We performed a gene ontology (GO) cluster analysis and found that mutant H-Ras-down-regulated genes were strongly associated with epidermis and ectoderm development as well as epithelial cell differentiation, further suggesting that H-Ras causes changes in epithelial differentiation (Fig. 1B) . There was a weaker, but significant, association of Ras-up-regulated genes with "response to wounding" and vasculature development (Fig. S1D ). Due to this regulation of epithelial-related genes in both the p53-del and WT-p53 lines, we chose to focus on this p53-independent aspect of H-Ras signaling. (For future reference, Dataset S1 B and C provides lists of genes regulated by H-Ras uniquely in either the WTp53 or p53-del background.)
We validated by qPCR that the level of p63, specifically its ΔNp63α isoform, is strongly reduced in the H-Ras cells and found that the ΔNp63α isoform is the predominant p63 isoform expressed in MCF10A cells, as has been described previously (34) (Fig. 1D and Dataset S1D). Furthermore, using intronic primers to measure pre-mRNA in the nucleus, we showed that p63 premRNA was similarly repressed by H-RasV12, indicating that ΔNp63α expression is regulated by Ras at the transcriptional level (Fig. 1E) .
To investigate more precisely how ΔNp63α expression is repressed by H-RasV12, we constructed promoter reporter genes with various lengths of an upstream p63 genomic sequence, starting with a construct containing −3,043 to +139 of the ΔNp63α promoter (35) . These reporters were transfected into the MCF10A cells (WT-p53) expressing Vector or H-Ras. We found that there was two-to threefold higher expression of the promoter constructs in Vector vs. H-Ras cells, after normalizing to the internal control of an SV40 promoter-Renilla luciferase plasmid (pRLSV40P) ( Fig. 2A ). Progressive deletion from the 5′ end resulted in reduced expression; however, each construct down to −100 showed similar differential expression between Vector and H-Ras cells. As controls, we found that the promoter activity of a p53 response element plasmid was not altered, whereas a minimal E-cadherin promoter was significantly lowered in Ras cells as expected, given the lower E-cadherin expression in these cells as discussed below (Fig. 2C) .
To separate the effects of the upstream promoter from the effects of the sequence surrounding the transcriptional start site (TSS), we tested the −100 to −30 region (just upstream of a TATA box) using a reporter with a minimal c-fos promoter. This sequence was similarly preferentially expressed in Vector cells (Fig. S2A) . We also tested a trimer of the −100 to −30 region and found even stronger Vector-specific activity (Fig. S2B ). The −83 to −30 region was also sufficient for this regulation; however, deletion of either the 5′ or 3′ part of this sequence caused a loss of promoter activity, suggesting that multiple sequences within this region are required in concert for proper regulation of expression (Fig. S2A ).
We were able to narrow down the region required for differential expression further to −83 to −44 ( Fig. 2B) . Examination of the sequence of this region showed a CCAAT box and potential SP1 site. When we made specific mutations along the −83 to −44 sequence (Fig. 2B , Left), altering CCAAT Box and Sp1 sites, promoter activity was completely abolished, whereas mutations in the other sites had only partial effects on expression (Fig. 2B , Right). We also tested the CCAAT Box and Sp1 mutations in the context of a longer promoter sequence, −500 to +139, and these mutations also displayed strongly decreased promoter activity (Fig. S2C) . Collectively, these results suggest the importance of the entire −83 to −44 region for regulation, and point to the CCAAT box and SP1 sites as being particularly critical.
Given the strong effects of the CCAAT box and SP1 site mutations, we tested whether the main factors associated with these sites bind to them in MCF10A cells using chromatin immunoprecipitation followed by qPCR. For the CCAAT box, a trimer of NF-YA/B/C is the primary binding factor (36, 37) , whereas SP1 binds to GC-rich boxes (38) . These factors were previously found to bind to the ΔNp63 promoter in mouse keratinocytes (39) . Although there were no differences in the expression levels of NF-YA or SP1 from immunoblotting in our MCF10A cell lines, we were able to detect their binding by chromatin immunoprecipitation to a sequence near the TSS of a known target, Thymidine Kinase 1 (Fig. 2D , Right). However, no binding was detected at the TSS of the ΔNp63α promoter above the binding of a nonspecific IgG control (Fig. 2D , Left). These results argue against an involvement of these factors in ΔNp63α regulation. It is possible that factors other than Sp1 and NF-YA bind to the above-mentioned sequences in the ΔNp63 promoter in contrast to the case in mouse keratinocytes. Importantly, when we measured binding of activated RNA polymerase II at the ΔNp63α TSS using antibodies to phosphoserine 5 of the C-terminal domain, there was a strong signal in Vector cells, but greatly decreased binding in H-Ras cells that was close to the background of the IgG control (Fig. 2D) . These results further confirm that ΔNp63α is regulated by H-RasV12 at the transcriptional level, affecting RNA polymerase II activity and leading to repression of ΔNp63α expression.
Given the changes in EMT-related genes seen by RNA-Seq, we tested by qPCR and Western blotting whether these genes were, in fact, regulated at both the protein and mRNA levels. The hallmark epithelial marker E-cadherin was suppressed, whereas the mesenchymal marker N-cadherin was activated by H-Ras at both levels ( Fig. 3A and Fig. S1E ). Similar to the mRNA levels, ΔNp63α protein was suppressed, whereas mesenchymal proteins Fibronectin and Vimentin were increased in H-Ras cells (Figs. 1D and 3A), demonstrating that these cells have undergone EMT. Although many reports have suggested that the transcription factors Twist, Snail, and Slug are regulators of the cadherin switch, it is likely they are not EMT inducers in this model due to the lack of RNA regulation (although we cannot rule out posttranscriptional regulation). Other known regulators driving EMT and E-cadherin repression are the ZEB1 and ZEB2 transcription factors (15, 40, 41) . In contrast to the first three inducers, these factors were strongly up-regulated in the H-Ras cells, suggesting that they are the likely regulators of EMT in these cells (Fig. 3 B and C) .
A well-known mechanism of suppression of the ZEB factors is by miR-205 and members of the miR-200 family (including miR200a, miR-200b, miR-200c, miR-141, and miR-429; henceforth, miR-200f) (42, 43) . These microRNAs (miRNAs) have also been reported to be regulated by p63 (27, 28, 44) , suggesting a pathway for ΔNp63α regulation of ZEB1/2. We validated that expression of miR-200b, miR-200c, and miR-205 was suppressed by H-Ras in the four cell lines, whereas there was no change in expression of a control miRNA, miR-375 (Fig. 3D) . These results are consistent with p63 regulation of ZEB1/2 through these miRNAs, although additional mechanisms are possible.
To test whether the effect of H-RasV12 was specific to the cell line used, we expressed H-RasV12 in an independent mammary epithelial cell line, MCF12A. This cell line is an immortalized, nontumorigenic breast epithelial cell line from a different patient than MCF10A, who also underwent reduction mammoplasty. The MCF12A H-RasV12 line similarly underwent EMT, displaying the same loss of E-cadherin and ΔNp63α, along with induction of N-cadherin, and Fibronectin ( Fig. S3 A and B) . Therefore, the downstream effects of H-Ras activation may be generalizable to multiple mammary epithelial cell lines.
Although mutant H-Ras is significantly overexpressed in the MCF10A cells, it is also possible that endogenous H-Ras is expressed at low levels in MCF10A cells. We therefore compared the levels of total Ras proteins using a pan-Ras antibody. In this case, the overexpression of Ras in our MCF10A cells is only threeto fourfold (Fig. S3C) . We also found that the levels of mutant Ras expressed in our engineered cell lines were only 2.5-to sevenfold higher than the level in a breast adenocarcinoma line Hs578T containing mutant H-Ras. The level of mutant Ras was also only onefold to 4.4-fold higher than the level in a colorectal carcinoma line HT-29 containing WT Ras (Fig. S3C) . These results suggest that the expression of mutant H-Ras in the MCF10A lines is within a range of physiological expression and that the observed effects cannot be attributed to grossly overexpressed Ras oncoprotein.
To understand more about the kinetics of the effects of Ras, we engineered a stable cell line with doxycycline-inducible H-RasV12, termed "TR-Hras." We found that it took about 5 d of H-Ras induction by doxycycline to cause both ΔNp63 and E-cadherin repression and to induce the mesenchymal markers N-cadherin, Fibronectin, and Zeb1 (Fig. S4 A and B) . These results further confirm the regulation of p63 and EMT by H-Ras. Also, these effects of H-RasV12 activity are not immediate; rather, they necessitate several days, as is common for induction of an EMT (45) .
Because activation of PI3K and loss of the phosphoinositide phosphatase phosphatase and tensin homolog (PTEN), which leads to hyperactive PI3K, are more common in breast cancers than Ras mutations, we expressed mutant H1047R of PIK3CA in MCF10A cells by retroviral transduction, establishing two clonal cell lines, P1 and P2 (Fig. 4A) . Hotspot mutations in the PI3K catalytic subunit PIK3CA, like H1047R, are found in nearly a quarter of breast cancers, and H1047R, in particular, was shown to lead, in turn, to strong activation of the Akt kinase, driving mammary tumorigenesis (8, 10, 46) . Clones P1 and P2 showed A B D C induced phosphorylation of Akt1, demonstrating its activation downstream of PI3K in both cell clones (Fig. 4A) . Note that the levels of exogenous PIK3CA H1047R expression are similar to the levels of the endogenous PIK3CA protein. The cells displayed fibroblast-like morphology, along with repression of ΔNp63α and E-cadherin, similar to the H-Ras cell lines (Fig. 4 A and B) . Mesenchymal genes were again up-regulated in these clones (Fig.  4B) . These results show that PIK3CA, a common breast cancer oncogene, can induce EMT and ΔNp63α repression and suggest that the effects of H-Ras may be due to its activation of PI3K/ Akt signaling.
To determine whether repression of ΔNp63α is sufficient to induce EMT, we made stable cell lines with shRNA to inhibit ΔNp63α expression. We established two clonal cell lines with independent shRNAs targeting the unique N terminus of ΔNp63. These clones displayed near-total inhibition of ΔNp63 mRNA and protein levels (Fig. 5A) . Concordantly, they exhibited characteristics of EMT, including loss of E-cadherin and gain of N-cadherin, Vimentin, Fibronectin, and Zeb1 expression (Fig. 5A and Fig.  S5A ). The epithelial-associated miRNAs showed strongly reduced expression, indicating that ΔNp63 is a key regulator (Fig. 5B) .
We also performed RNA-Seq on the control (LMP vector) and sh-ΔNp63 lines, and identified 2,255 genes that were significantly altered by both ΔNp63 shRNAs (Dataset S2A). GO 
GOs downregulated by H-Ras and p63 shRNAs p value
Ectoderm development 3.13E-13
Epidermis development 2.96E-11

Epithelium development 1.16E-08
Epithelial cell differentiation 6.71E-07 migration and adhesion (Fig. S5B) . Upon comparison of the shΔNp63-regulated genes with the mutant Ras-regulated genes, 380 overlapping targets were identified ( Fig. 5C and Dataset S2B), indicating that p63 regulates an appreciable subset of the genes that H-Ras controls. We performed GO analysis on the genes down-regulated by both perturbations and again found many processes related to changes in epithelial differentiation and development (Fig. 5C ). Epithelial-specific genes, such as MIR205HG, KRT5, CDH1, ESRP1, and GRHL2, were significantly down-regulated following both alterations. The loss of these genes further demonstrated that the induction of EMT in these cells is due to circuits controlled by Ras and p63. When we analyzed several transcription factors among genes uniquely regulated by H-Ras (Dataset S2C) in preliminary experiments, we did not identify any one factor as being sufficient to control p63 or induce EMT. It is possible that several factors coordinately regulate this pathway, or it is feasible that other targets are regulated posttranscriptionally to control EMT.
Keratinocyte differentiation
Collagen I is a major component of extracellular matrix (ECM) in human breast tissue and is known to support growth of MCF10A mammospheres (47) . Because H-Ras-controlled EMT has been associated with metastasis (48, 49), we examined 3D cell invasiveness in 3D collagen I gels. For these assays, we embedded spheroids consisting of 5,000 cells into collagen I matrices and then monitored any outward cellular invasion into the fibrillar matrix 24 h later. Under these conditions, cell proliferation is minimal. We found that Vector cells only spread from the spheroid in a sheet-like manner, exhibiting a closed front characteristic of epithelial growth (Fig. 6A) . In contrast, H-RasV12 and sh-ΔNp63α cells demonstrated extensive invasion of individual cells into the ECM (Fig. 6A) . We quantified the change in invasive behavior by counting the number of single cells that left the spheroid. Although few cells invaded beyond the spheroid core formed by the Vector cells, a significant number left the core of H-RasV12 and shΔNp63α spheroids (Fig. 6B ). This invasive behavior was consistent with a shift to a more mesenchymal phenotype.
Adhesion and force generation on ECM via integrin receptors are prerequisites for mesenchymal locomotion in 3D environments, such as the collagen I matrices used here (50) . Radial alignment of collagen fibers at the spheroid surface is a robust indicator of integrin-dependent interaction with the ECM (51, 52) . To exclude the possibility that invasion differences were caused by variations in the cells' abilities to establish contacts with the collagen matrix, we imaged them soon after embedment (t = 2 h) with confocal reflectance microscopy, which allows for the visualization of collagen fibers. In each case, we observed collagen fibers radially aligned to the spheroid surface, indicating comparable cell-matrix attachments (Fig. S6) . Thus, the observed differences in invasive behavior cannot be attributed to insufficient surface presentation among the MCF10A-derived lines.
To determine whether p63 levels in tumors might be similarly regulated as in Ras-transformed MCF10A cells, we looked at expression of the p53 family in paired normal/tumor samples from The Cancer Genome Atlas Breast Cancer dataset (9) . In fact, p63 expression was significantly lower in tumor samples relative to their normal tissue counterparts, whereas there was little change in p53 and p73 expression (Fig. 7A) . This finding suggests that although p63 is not frequently mutated in cancers, its expression is commonly lowered by tumorigenic mechanisms.
It was also possible that because p63 is expressed in basal but not luminal epithelial cells (20) , the low p63 expression was simply due to a predominance of nonbasal tumors. However, after stratifying a larger breast cancer dataset of tumors by molecular subtype according to the PAM50 (Predication analysis of microarrays 50) gene set (53) , p63 expression in basal-like breast cancers remained close to zero and was therefore significantly lower than that in normal tissue (Fig. 7B) . In fact, expression of p63 in basal tumors was comparable to expression of p63 in luminal-type tumors, which would not be expected to express p63. Finally, we examined a tissue microarray (TMA) of triple-negative breast cancer (TNBC) tissues for p63 protein expression. Various studies have shown that the majority of basal-like breast cancers fall within the TNBC subtype, and that these cancers express basal cytokeratins (54, 55) . However, in 94% of these patient samples, p63 was expressed in ≤5% of tumor nuclei (Dataset S3). Together, these results show that p63 expression is greatly reduced in a preponderance of breast cancers and support our model that oncogene down-regulation of this gene is important for tumor progression. We cannot rule out, however, that basal tumors originate in luminal progenitors as has been reported for basal tumors from BRCA1 carriers (56, 57) .
Discussion
We have found that ectopic expression of mutant H-Ras and PIK3CA in MCF10A cells leads to down-regulation of ΔNp63 and transdifferentiation of these cells to a more mesenchymal phenotype. This process was accompanied by a distinct change in invasive behavior, suggesting that the transdifferentiation process, as orchestrated by the EMT, leads to greater metastatic potential. Depletion of ΔNp63 with shRNA also caused EMT, demonstrating that this depletion is also sufficient to induce the transition. Along with other evidence that ΔNp63 is required for epithelial stratification (16, 18) , these results confirm that ΔNp63 is a master regulator of the epithelial state. ΔNp63 activates expression of epithelial-specific miRNAs that are repressors of the mesenchymal-inducing transcription factors Zeb1 and Zeb2. These factors directly repress E-cadherin expression, suggesting a pathway for induction of an EMT from Ras to ΔNp63 to E-cadherin (Fig. 7C ).
There are many afferent signaling pathways that can induce an EMT (39) . TGF-β was one of the first characterized inducers of this transition, and signaling from Ras and TGF-β can synergistically drive cells toward a more mesenchymal state (58, 59 ). We have not observed activation of the TGF-β pathway in our MCF10A-Ras cells, suggesting that they are driven to EMT independent of TGF-β. Because we found that mutant PIK3CA phenocopied the H-Ras cells, we postulate that a factor(s) within the PI3K/Akt signaling pathway is responsible for direct repression of the ΔNp63 promoter and induction of EMT, independent of the TGF-β pathway.
We were concerned that the MCF10A cell lines we generated markedly overexpress mutant H-Ras compared with the endogenous H-Ras in the control cell lines and that this overexpression might cause nonphysiological effects. However, the levels of total Ras proteins (H-, K-and N-Ras) were more modestly overexpressed, and there was one-to sevenfold higher expression than endogenous Ras compared with two human cancer cell lines that were tested (Fig. S3C) . Although we cannot rule out spurious effects of high levels of ectopic mutant H-Ras in MCF10A cells, the PIK3CA cell lines we generated expressed p110α protein at levels similar to the endogenous protein.
Because PIK3CA mutations are common in breast cancer, our results suggest that physiological levels of mutant PIK3CA can have effects on EMT during breast cancer progression and that the similar effects of H-Ras overexpression in our cell lines on EMT are physiological. Further work will be required in mammary tumor models to test the importance of oncogene repression of p63 and activation of EMT.
We mapped a short region of the ΔNp63 promoter required for differential expression in Ras-transformed cells. Although the entire region of −83 to −44 is required, the CCAAT box and SP1 sites were particularly critical. A similar requirement for these sites for ΔNp63 expression was also found in mouse keratinocytes (60). However, although Romano et al. (60) (27, 28, 42, 43) (Fig. 7C) . We found that these miRNAs are strongly repressed by H-Ras and ΔNp63 depletion in MCF10A cells, consistent with this pathway leading to regulation of E-cadherin and EMT.
Consistent with our data linking repression of ΔNp63 with the occurrence of EMT, analysis of the The Cancer Genome Atlas (TCGA) breast cancer dataset shows that breast tumors contain low ΔNp63 expression compared with normal tissue. In particular, our analyses revealed that basal-like cancers and TNBCs have low ΔNp63 expression. In addition, it should be noted that there have been many other reports of low p63 expression in breast cancers (32, 64, 65) . There are, however, cases where high p63 expression is seen in breast tumors (56, 65, 67) . We propose that these cases represent a distinct type of breast carcinoma similar to esophageal squamous carcinomas, which have high p63 (57, 68) . These tumors appear to have a more stratified epithelial nature and may use a separate pathway to tumorigenesis.
The cell of origin of basal-like breast cancers from BRCA1 mutation carriers may actually be a luminal progenitor cell; such cells have similar gene expression patterns to patient basal-like tumors (69, 70) . It is currently unknown whether all basal-like breast cancers derive from luminal progenitors and not just those breast cancers with BRCA1 alterations. Indeed, there may be several differentiation pathways for cells of origin for breast cancers. Multipotent and unipotent mammary cell progenitors have been characterized and would provide alternative stem cell-like cells for breast cancer initiation (reviewed in ref. 71) . Some basal myoepithelial cells also have mammary stem cell properties in that they are able to repopulate a mammary gland in vivo (72) , raising the possibility that basal myoepithelial cells may also be able to function as cancer stem cells and as a cell of origin for basal-like tumors. It is possible that oncogenes, such as H-RAS and PIK3CA, could participate in transformation of these basal-like mammary stem cells, and subsequently induce their gain of mesenchymal properties. The further determination of cells of origin for different types of breast cancer is key to understanding breast cancer development and subsequent differentiation of breast cancer cells by EMT or to other fates.
There is considerable evidence that EMT contributes to cancer progression and metastasis, as well as inducing stem cell properties (73) . EMT is also known to induce individual cell migration, which is a property we observed after Ras pathway activation and ΔNp63 depletion (13, 73, 74) . However, two recent papers have concluded rather provocatively that EMT is not required for metastasis, although it increases chemoresistance (75, 76) . It is unclear if these conclusions hold true for human breast cancer, so further manipulation of EMT will be required to determine its role in different cancer types.
In conclusion, the strong repression of ΔNp63 by H-RAS and PIK3CA and induction of EMT suggest that this process is critical for mammary tumorigenesis. Future studies must determine how important this pathway is to human breast cancer progression and how p63 regulation influences pathogenesis. A more detailed understanding of this pathway may lead to an alternate approach to block this extremely prevalent disease.
Materials and Methods
A comprehensive methods section is available in Supporting Information. A brief summary follows.
Retroviral vectors were used to express H-RasV12, PI3KCA-H1047R, and FLAG-ΔNp63α in MCF10A cells with or without p53 deletion (30) . Tet-on H-RasV12 cells were made in the MCF10A-TR cell line (77) using a lentiviral H-RasV12 vector. The shRNA cell lines were made with short hairpin sequences to ΔNp63 (unique to the N-terminal coding region).
Protein extraction, Western blotting, chromatin immunoprecipitation (ChIP), and qPCR, to measure mRNA and miRNA levels, were performed by standard methods. Luciferase assays were performed using the Dual-Luciferase Reporter Assay (Promega) with the indicated firefly luciferase reporters and an internal control of the Renilla luciferase vector pRLSV40P. Sequences of oligonucleotides used for qPCR, ChIP, and shRNAs are shown in Dataset S4.
For the invasion assay, spheroids were formed using a previously described centrifugation method (78) that results in multicellular spheroids surrounded by a shell of basement membrane. Single spheroids were collected, and each was added to a collagen solution followed by collagen gelation. For assessment of cell invasion, live cell imaging was performed. At least 20 spheroids were imaged for each condition from two independent experiments. Only cells completely distinct from the spheroid core at t = 24 h were counted. Collagen was imaged via confocal reflectance microscopy with the 488-nm laser at t = 2 h after spheroid embedding.
Bioinformatic analysis of TCGA datasets are described in Supporting Information. For RNA-Seq, mRNA was isolated from total RNA using oligo-dT beads (Thermo Fisher). RNA-Seq was carried out by C&K Genomics (Vector and H-Ras cells) and Macrogen (LMP and sh-ΔNp63 cells). The H-Ras RNA-Seq data were deposited in the Gene Expression Omnibus (www.ncbi.nlm.nih. gov/geo/) under accession number GSE81593. Data from the sh-ΔNp63 RNASeq are hosted at a Columbia University website (biology.columbia.edu/ privesngs). Differentially expressed genes were filtered using the criteria of fold change > 2.0 and P < 0.05 (adjusted using the Benjamini-Hochberg procedure) (79) . Only genes above a threshold for expression in the positive cell lines were included.
Three TNBC TMAs were constructed under Columbia University Medical Center Institutional Review Board protocol AAAB2667 (Research with Human Surgical Specimens). Invasive breast cases negative for estrogen and progesterone receptor expression and Her2-negative for overexpression were collected with informed consent. Three cores of invasive breast carcinoma, and, in many cases, three cores of adjacent normal (nonneoplastic) breast tissue were represented per case in the array. The ΔNp63 antibody from Santa Cruz Biotechnology (sc-71825) was used at a ratio of 1:100.
